![Charlotte Pahl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charlotte Pahl
Direktor/Vorstandsmitglied bei Reponex Pharmaceuticals A/S
Vermögen: 157 152 $ am 30.06.2024
Aktive Positionen von Charlotte Pahl
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Reponex Pharmaceuticals A/S
![]() Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Charlotte Pahl
Statistik
International
Dänemark | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Reponex Pharmaceuticals A/S
![]() Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million. | Health Technology |
- Börse
- Insiders
- Charlotte Pahl
- Erfahrung